ATE36331T1 - GUANINE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND THEIR ANTIVIRAL ACTIVITIES. - Google Patents

GUANINE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND THEIR ANTIVIRAL ACTIVITIES.

Info

Publication number
ATE36331T1
ATE36331T1 AT84301089T AT84301089T ATE36331T1 AT E36331 T1 ATE36331 T1 AT E36331T1 AT 84301089 T AT84301089 T AT 84301089T AT 84301089 T AT84301089 T AT 84301089T AT E36331 T1 ATE36331 T1 AT E36331T1
Authority
AT
Austria
Prior art keywords
compositions containing
antiviral activities
guanine derivatives
infections
acid
Prior art date
Application number
AT84301089T
Other languages
German (de)
Inventor
Kelvin K Ogilvie
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Application granted granted Critical
Publication of ATE36331T1 publication Critical patent/ATE36331T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)

Abstract

2-(N,N-dialkylaminomethylene)-9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl] guanines and their salts are of utility in the treatment of viral infections, and in particular for combatting herpes virus type 1 infections. They may be formulated in compositions together with an interferon, phosphonoformic acid or phosphonoacetic acid, for synergic activity.
AT84301089T 1983-02-23 1984-02-20 GUANINE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND THEIR ANTIVIRAL ACTIVITIES. ATE36331T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/468,877 US4461757A (en) 1983-02-23 1983-02-23 Dimethylaminomethylenated anti-herpes compounds
EP84301089A EP0119757B1 (en) 1983-02-23 1984-02-20 Guanine derivatives, compositions containing them, and their anti-viral use

Publications (1)

Publication Number Publication Date
ATE36331T1 true ATE36331T1 (en) 1988-08-15

Family

ID=23861607

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84301089T ATE36331T1 (en) 1983-02-23 1984-02-20 GUANINE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND THEIR ANTIVIRAL ACTIVITIES.

Country Status (10)

Country Link
US (1) US4461757A (en)
EP (1) EP0119757B1 (en)
JP (1) JPS59186985A (en)
AT (1) ATE36331T1 (en)
AU (1) AU2462284A (en)
CA (1) CA1225641A (en)
DE (1) DE3473272D1 (en)
DK (1) DK79784A (en)
MC (1) MC1575A1 (en)
ZA (1) ZA841241B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5147636A (en) * 1982-11-09 1992-09-15 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons
US4565868A (en) * 1983-02-07 1986-01-21 Syntex (U.S.A.) Inc. Process for preparing guanine derivatives
US5684153A (en) * 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
DE3485225D1 (en) * 1983-08-18 1991-12-05 Beecham Group Plc ANTIVIRAL GUANINE DERIVATIVES.
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
US4636383A (en) * 1984-08-29 1987-01-13 Schering Corporation Interferon-cyclaradine combination
IL76591A0 (en) 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
GB8628826D0 (en) * 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
WO2013023362A1 (en) * 2011-08-16 2013-02-21 深圳市卫武光明生物制品有限公司 Cytomegalovirus human immunoglobulin for intravenous injection, and preparation method therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent

Also Published As

Publication number Publication date
AU2462284A (en) 1984-08-30
US4461757A (en) 1984-07-24
DE3473272D1 (en) 1988-09-15
JPS59186985A (en) 1984-10-23
EP0119757B1 (en) 1988-08-10
EP0119757A3 (en) 1985-08-28
CA1225641A (en) 1987-08-18
DK79784D0 (en) 1984-02-20
DK79784A (en) 1984-08-24
MC1575A1 (en) 1985-02-04
ZA841241B (en) 1984-12-24
EP0119757A2 (en) 1984-09-26

Similar Documents

Publication Publication Date Title
ATE91233T1 (en) ANTIVIRAL PHARMACEUTICAL COMPOSITIONS AND THEIR USE.
LV5273A3 (en) Satisfaction with the production of pirimidine nucleosides
BR9815166A (en) "method of inhibiting virus replication, compound, method of inhibiting cytomegalovirus replication, antiviral compound, use of a compound, pharmaceutical composition, pharmaceutical composition inhibiting virus and cytomegalovirus replication and antiviral pharmaceutical composition"
FI20001231A7 (en) 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives and their analogues and their use as antiviral agents
DE3581819D1 (en) PYRIDAZINE AMINS EFFECTIVE AGAINST VIRUSES.
ATE36331T1 (en) GUANINE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND THEIR ANTIVIRAL ACTIVITIES.
IL86040A (en) Acid stable purine dideoxynu- cleosides, their preparation and pharmaceutical compositions containing them
ATE231839T1 (en) POLYAROMATIC ANTIVIRAL COMPOSITIONS
DE3480828D1 (en) ANTIVIRAL COMPOSITIONS.
DK326586D0 (en) ANTIVIRAL PYRIMIDIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS AND PREPARATIONS OF THE COMPOSITIONS
DK102892A (en) PURIN DERIVATIVES, PHARMACEUTICAL PREPARATIONS COMPREHENSIVE, AND INTERNAL USE RELATIONS
DK178188A (en) ANTIVIRUS AGENT
FI803202L (en) PHOSPHONOHYDROXIAETHYCLE FOERFARANDE FOER DESS FRAMSTAELLNING OCH DESS ANVAENDNING SAOSOM CEILING MODEL
ATE40854T1 (en) THERAPEUTIC COMPOSITIONS WITH ANTIVIRAL ACTIVITY.
ATE26267T1 (en) PYRIMIDINE DERIVATIVES, EQUIPPED WITH ANTIVIRAL ACTION.
FR2342972A2 (en) PURINE DERIVATIVES FOR USE AS MEDICINAL PRODUCTS FOR THE TREATMENT OF VIRAL INFECTIONS
IT1178809B (en) TETRAETHYLMONIUM COMOSTO FOR USE IN THE TREATMENT OF DISEASES CAUSED BY HERPETIC VIRUSES
ATE104676T1 (en) ANTIVIRAL INGREDIENTS.
GR3017335T3 (en) Oligophosphates with antiviral activity.
JPS5214770A (en) Preparation of ng-substituted-n2-cumarin sulfonylalginamides and their acid addition salts
YU106191A (en) AMINOBENZODIAZEPINI
BR8404558A (en) TREATMENT OF DISEASES CAUSED BY HERPES VIRUSES

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee